SREBF1 and Hyperglycemia: Notably, CA treatment also suppressed SREBP1, FAS, and ACC in the livers of control rats, despite the presence of elevated FFAs, hyperglycemia, and inflammatory cytokines dissipating their role in the stimulatory effect of CA on proteins of lipid synthesis.